SRPK1 and breast carcinoma: Additionally, work published by Lin et al also suggests that SRPK1 may exert some of its tumourigenic effects in breast cancer through RNA‐binding motif protein 4‐mediated reduction in the expression of pro‐apoptotic IR‐B and MCL‐1S transcripts, thereby modulating sensitivity to apoptotic signals 14.